Journal of Rheumatic Diseases

Download original image
Fig. 3. The drug survival rate of TNF inhibitors and abatacept over 24 months by Kaplan–Meier estimates. (A) Plot with respect to SE status. (B) Plot with respect to ACPA status. ABTC: abatacept, ACPA: anti-citrullinated protein antibody, SE: shared epitope, TNFi: tumor necrosis factor inhibitors, HR: hazard ratio, CI: confidence interval.
J Rheum Dis 2022;29:171~180 https://doi.org/10.4078/jrd.2022.29.3.171
© J Rheum Dis